A. Gasco

发表

CHF 2206, a new potent vasodilating and antiaggregating drug as potential nitric oxide donor.

M. Civelli, P. Caruso, M. Giossi, 1994, European journal of pharmacology.

S35b, a new phenylsulfonylfuroxan compound, inhibits thrombin-induced synthesis of platelet-activating factor and prostacyclin in human endothelial cells

R. Fruttero, R. Heller, F. Bussolino, 1993, Agents and Actions.

Characterization of a new compound, S35b, as a guanylate cyclase activator in human platelets.

R. Fruttero, A. Gasco, R. Heller, 1992, Biochemical pharmacology.

Activation of endothelial guanylate cyclase inhibits cellular reactivity.

R. Heller, F. Bussolino, D. Ghigo, 1995, Agents and actions. Supplements.

4-Methyl-3-(arylsulfonyl)furoxans: a new class of potent inhibitors of platelet aggregation.

R. Fruttero, D. Ghigo, A. Bosìa, 1992, Journal of medicinal chemistry.

The involvement of the release of nitric oxide in the pharmacological activity of the new furoxan derivative CHF 2363

M. Civelli, P. Caruso, M. Giossi, 1996, British journal of pharmacology.

In vitro and in vivo vasodilating activity of nitroso derivatives gem -substituted with electron-withdrawing groups.

C. Medana, D. Ghigo, A. Bosìa, 2000, Pharmacological research.

New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities.

C. Cena, A. Gasco, G. Ermondi, 1998, Journal of medicinal chemistry.

A new class of furoxan derivatives as NO donors: mechanism of action and biological activity

R. Fruttero, C. Medana, M. Civelli, 1995, British journal of pharmacology.

Glutathione potentiates cGNP synthesis induced by the two phenylfuroxancarbonitrile isomers in RFL-6 cells

C. Cena, A. Gasco, D. Ghigo, 1996 .